{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:44:54Z","timestamp":1785725094874,"version":"3.56.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007479","name":"Fondazione Cassa di Risparmio di Padova e Rovigo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Among white people, the incidence of cutaneous malignant melanoma (CMM) has been increasing steadily for several decades. Meanwhile, there has also been a significant improvement in 5-year survival among patients with melanoma. This population-based cohort study investigates the five-year melanoma-specific survival (MSS) for all melanoma cases recorded in 2015 in the Veneto Tumor Registry (North-Est Italian Region), taking both demographic and clinical-pathological variables into consideration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The cumulative melanoma-specific survival probabilities were calculated with the Kaplan-Meier method, applying different sociodemographic and clinical-pathological variables. Cox\u2019s proportional hazards model was fitted to the data to assess the association between independent variables and MSS, and also overall survival (OS), calculating the hazard ratios (HR) relative to a reference condition, and adjusting for sex, age, site of tumor, histotype, melanoma ulceration, mitotic count, tumor-infiltrating lymphocytes (TIL), and stage at diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with stage I melanoma, the risk of death was increased for stage II (HR 3.31, 95% CI: 0.94-11.76, p=0.064), almost ten times higher for stage III (HR 10.51, 95% CI: 3.16-35.02, p&amp;lt;0.001), and more than a hundred times higher for stage IV (HR 117.17, 95% CI: 25.30-542.62, p&amp;lt;0.001). Among the other variables included in the model, the presence of mitoses and histological subtype emerged as independent risk factors for death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The multivariable analysis disclosed that older age, tumor site, histotype, mitotic count, and tumor stage were independently associated with a higher risk of death. Data on survival by clinical and morphological characteristics could be useful in modelling, planning, and managing the most appropriate treatment and follow-up for patients with CMM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.737399","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T04:50:22Z","timestamp":1637038222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Alessandra","family":"Buja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De Toni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Fusinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Vecchiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Del Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mocellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Riccardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12236","article-title":"Trends in Incidence and Predictions of Cutaneous Melanoma Across Europe Up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.jaad.2011.04.032","article-title":"Recent Trends in Cutaneous Melanoma Incidence and Death Rates in the United States, 1992-2006","volume":"65","author":"Jemal","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000017969","article-title":"Semiological Value of ABCDE Criteria in the Diagnosis of Cutaneous Pigmented Tumors","volume":"197","author":"Thomas","year":"1998","journal-title":"Dermatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-46227-7_6","article-title":"Epidemiology of Skin Cancer: Update 2019","volume":"1268","author":"Leiter","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B5","volume-title":"SEER Cancer Statistics Review, 1975-2018","author":"Howlader","year":"2021"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S99021","article-title":"Stage-Specific Survival and Recurrence in Patients With Cutaneous Malignant Melanoma in Europe - A Systematic Review of the Literature","volume":"8","author":"Svedman","year":"2016","journal-title":"Clin Epidemiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.05.034","article-title":"Clinical and Histopathological Risk Factors to Predict Sentinel Lymph Node Positivity, Disease-Free and Overall Survival in Clinical Stages I-II AJCC Skin Melanoma: Outcome Analysis From a Single-Institution Prospectively Collected Database","volume":"45","author":"Mandal\u00e0","year":"2009","journal-title":"Eur J Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/s0959-8049(97)10119-8","article-title":"Skin Melanoma in Italy: A Population-Based Study on Survival and Prognostic Factors","volume":"34","author":"Balzi","year":"1998","journal-title":"Eur J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.3198","article-title":"Sentinel and Nonsentinel Node Status in Stage IB and II Melanoma Patients: Two-Step Prognostic Indicators of Survival","volume":"24","author":"Cascinelli","year":"2006","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0273-8","article-title":"Clinical Considerations on Sentinel Node Biopsy in Melanoma From an Italian Multicentric Study on 1,313 Patients (SOLISM-IMI)","volume":"16","author":"Testori","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B11","unstructured":"High Resolution Registry of Melanoma and Care Pathways Monitoring in the Veneto Region, Italy\n            GuzzinatiS\n            ZorziM\n            RossiCR\n            BujaA\n            ItalianoI\n            FioreAR\n          CopenaghenENCR Scientific Meeting"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-019-02064-4","article-title":"Mitotic Rate as an Important Prognostic Factor in Cutaneous Malignant Melanoma","volume":"21","author":"Pi\u00f1ero-Madrona","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to Build a Bridge From a Population-Based to a More \u201cPersonalized\u201d Approach to Cancer Staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ssu.10020","article-title":"New TNM Melanoma Staging System: Linking Biology and Natural History to Clinical Outcomes","volume":"21","author":"Balch","year":"2003","journal-title":"Semin Surg Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4813","article-title":"An Observational Study Regarding the Rate of Growth in Vertical and Radial Growth Phase Superficial Spreading Melanomas","volume":"12","author":"Betti","year":"2016","journal-title":"Oncol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2504","article-title":"Pathology of Melanoma","author":"Elder","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy086","article-title":"Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy","volume":"111","author":"Lattanzi","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2005.00310.x","article-title":"The Importance of Mitotic Rate as a Prognostic Factor for Localized Cutaneous Melanoma","volume":"32","author":"Barnhill","year":"2005","journal-title":"J Cutan Pathol"},{"key":"B20","first-page":"383","article-title":"Malignant Melanoma: A Multivariate Analysis of Prognostic Factors","volume":"24","author":"Vollmer","year":"1989","journal-title":"Pathol Annu"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3531","article-title":"Mitotic Rate Is a More Reliable Unfavorable Prognosticator Than Ulceration for Early Cutaneous Melanoma: A 5-Year Survival Analysis","volume":"32","author":"Donizy","year":"2014","journal-title":"Oncol Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.04.016","article-title":"Tumor Mitotic Rate Is an Independent Predictor of Survival for Nonmetastatic Melanoma","volume":"164","author":"Evans","year":"2018","journal-title":"Surgery"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database","volume":"29","author":"Thompson","year":"2011","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33088","article-title":"Reappraisal of the Prognostic Significance of Mitotic Rate Supports its Reincorporation Into the Melanoma Staging System","volume":"126","author":"Kashani-Sabet","year":"2020","journal-title":"Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14485","article-title":"Is Mitotic Rate Still Useful in the Management of Patients With Thin Melanoma","volume":"31","author":"Tejera-Vaquerizo","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"adv00323","DOI":"10.2340\/00015555-3680","article-title":"Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients With Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics","volume":"100","author":"Damiani","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30432-0","article-title":"Gastric Cancer Risk: Between Genetics and Lifestyle","volume":"21","author":"Rugge","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.737399\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T04:50:27Z","timestamp":1637038227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.737399\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":27,"alternative-id":["10.3389\/fonc.2021.737399"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.737399","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"article-number":"737399"}}